Intracranial Pressure (ICP) Monitoring Devices Market Analysis By Technique (Invasive, Noninvasive), By Application (Traumatic Brain Injury, Intracerebral Hemorrhage, Meningitis, Subarachnoid Hemorrhage, Others), And Segment Forecasts, 2018 - 2025

Industry Insights

The global intracranial pressure monitoring devices market is expected to reach USD 1.9 billion by 2025 and is projected to grow at a CAGR of 6.5% over the forecast period. The rising prevalence of neurological disorders and traumatic accidents is expected to propel the market growth of ICP monitoring devices. In addition, escalating cases of brain infection, aneurysm, and meningitis among the global population would result in increased requirement for ICP monitoring, hence affecting the growth of the market positively.

U.S. ICP monitoring devices market, by technique, 2014 - 2025 (USD Million)

In developing countries, governments are continuously investing huge amount of funds to improve patient-centered care, safety, and efficiency. Increasing geriatric population base, rising prevalence of head injuries, and rapid growth in foreign investments are expected to be witnessed over the forecast period in the developing nations of Asia Pacific and Middle Eastern region.

Technique Insights

External Ventricular Drainage (EVD) dominated the invasive technique space with largest revenue share in 2015, because the method is considered as a gold standard for the measurement of accurate ICP, which is driving the penetration of these systems in hospitals and emergency care centers to a great extent.

Noninvasive techniques are further segmented into transcranial Doppler ultrasonography, tympanic membrane displacement, Optic Nerve Sheath Diameter (ONSD), MRI/CT, and fundoscopy (papilledema). The MRI/CT segment accounted for the largest market share in 2015. However, ONSD is expected to grow at the fastest CAGR over the forecast period due to its ease of use and noninvasiveness. Moreover, ONSD has proved to be the most appropriate modality available for emergency medical situations.

Application Insights

The traumatic brain injury application segment accounted for the largest market share in 2015 owing to its vast prevalence at a global level over the years. According to the Centers for Disease Control and Prevention, traumatic brain injury accounted for approximately 2.5 million emergency department visits, hospitalizations, and deaths in the U.S.

Global intracranial pressure monitoring devices market, by application, 2015

However, the others segment, which includes CNS infection and brain edema, is anticipated to foresee the highest growth rate over the forecast period. Continuous measurement of raised ICP enables early treatment of CNS infection, by maintenance adequate cerebral perfusion pressure. In addition, brain edema results in an increased ICP in the posterior fossa, which requires accurate measurement of ICP for early and effective treatment. Hence, a major chunk of the global population suffering from edema or CNS infection is relying on ICP measurement for better and early treatment of such diseases. Hence, the others segment is expected to grow at the fastest CAGR during the forecast period.

Regional Insights

North America dominated the ICP monitoring devices market with largest revenue share in 2015. The dominance of this region was mainly attributed to the increased healthcare infrastructure, high adoption of advanced ICP monitoring devices, and the presence of large patient pool. In addition, increasing prevalence of numerous neurological disorders is aggressively propelling the demand for ICP monitoring systems. According to the North American Brain Injury Society, approximately 5.3 million Americans are living with disability related to traumatic brain injury.

On the other hand, Asia Pacific is expected to witness the fastest growth during the forecast period. Due to availability of a large population suffering from brain disorders, greater than ever initiatives are being undertaken by the governments, and presence of various well-established hospitals and critical care centers would boost the growth of the market in Asia Pacific region. These factors are expected to increase the application of ICP monitoring systems in this region, thereby positively impacting the growth of the Asia Pacific market.

Competitive Insights

Some key players in this industry include Medtronic plc; Integra LifeSciences Holdings Corporation; and Codman & Shurtleff, Inc. These players are mostly present in the international space and due to easy accessibility to the global market, are currently trying to compete in order to gain higher market share. Some of the other players operating in the market include RAUMEDIC AG; Vittamed; Sophysa Ltd.; Orsan Medical Technologies; and Spiegelberg GmbH & Co. KG.

Report Scope

Segments Covered in the Report

This report forecasts revenue growth at global, regional, & country levels as well as provides an analysis on the latest trends and opportunities in each of the sub segments from 2014 to 2025. For the purpose of this study, Grand View Research has segmented the ICP monitoring devices market on the basis of technique, application, and region:

• Technique Outlook (Revenue, USD Million, 2014 - 2025)

  • Invasive

    • External Ventricular Drainage (EVD)

    • Microtransducer ICP Monitoring

  • Noninvasive

    • Transcranial Doppler Ultrasonography

    • Tympanic Membrane Displacement (TMD)

    • Optic Nerve Sheath Diameter

    • MRI/CT

    • Fundoscopy (papilledema)

• Application Outlook (Revenue, USD Million, 2014 - 2025)

  • Traumatic Brain Injury

  • Intracerebral Hemorrhage

  • Meningitis

  • Subarachnoid Hemorrhage

  • Others (cerebral edema, CNS infection, etc.)          

• Regional Outlook (Revenue, USD Million, 2014 - 2025)

  • North America

    • U.S.

    • Canada

  • Europe

    • UK

    • Germany

  • Asia Pacific

    • Japan

    • China

  • Latin America

    • Brazil

    • Mexico

  • MEA

    • South Africa